Ionis Pharmaceuticals (IONS) Change in Inventory (2013 - 2026)
Ionis Pharmaceuticals (IONS) recorded quarterly Change in Inventory of -$338000.0 in Q1 2026, up 63.5% quarter-over-quarter from -$926000.0 in Q4 2025, and up 66.53% on a YoY basis from -$202960.8 in Q1 2025.
Ionis Pharmaceuticals (IONS) Change in Inventory (2013 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Change in Inventory history runs 14 years deep, the most recent figure standing at -$338000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 66.53% year-over-year to -$338000.0; the TTM figure through Mar 2026 stood at $14.3 million (up 214.61% YoY), while the FY2025 annual figure was $13.7 million, up 169.65% from the prior year.
- Change in Inventory was -$338000.0 for Q1 2026 at Ionis Pharmaceuticals, up from -$926000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $13.5 million in Q2 2025 to a low of -$4.2 million in Q2 2022.
- Historically, Change in Inventory has averaged $914705.9 across 5 years, with a median of -$271000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Change in Inventory sank 430.77% in 2022, then soared 1590.72% in 2025.
- A 5-year view of Change in Inventory shows it stood at -$1.2 million in 2022, then advanced by 2.83% to -$1.1 million in 2023, then surged by 545.58% to $5.0 million in 2024, then tumbled by 118.36% to -$926000.0 in 2025, then surged by 63.5% to -$338000.0 in 2026.
- The last three Change in Inventory figures came in at -$338000.0 (Q1 2026), -$926000.0 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ionis Pharmaceuticals | 12.23 Bn | 10.31 Bn | 243.11 Mn | -338,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -338,000.00 |
| Mar 31, 2026 | -338,000.00 |
| Dec 31, 2025 | -926,000.00 |
| Dec 31, 2025 | -926,000.00 |
| Sep 30, 2025 | 2.14 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 13.48 Mn |
| Jun 30, 2025 | 13.48 Mn |
| Mar 31, 2025 | -1.01 Mn |
| Mar 31, 2025 | -1.01 Mn |
| Dec 31, 2024 | 5.04 Mn |
| Dec 31, 2024 | 5.04 Mn |
| Sep 30, 2024 | -271,000.00 |
| Sep 30, 2024 | -271,000.00 |
| Jun 30, 2024 | 797,000.00 |
| Jun 30, 2024 | 797,000.00 |
| Mar 31, 2024 | -499,000.00 |
| Mar 31, 2024 | -499,000.00 |
| Dec 31, 2023 | -1.13 Mn |
| Dec 31, 2023 | -1.13 Mn |